nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A3—coronary artery disease	0.336	1	CbGaD
Procainamide—BCHE—Perindopril—coronary artery disease	0.0688	0.242	CbGbCtD
Procainamide—BCHE—Ramipril—coronary artery disease	0.057	0.2	CbGbCtD
Procainamide—SLC22A5—Niacin—coronary artery disease	0.0522	0.183	CbGbCtD
Procainamide—SLC22A5—Furosemide—coronary artery disease	0.0343	0.121	CbGbCtD
Procainamide—SCN5A—purkinje fiber—coronary artery disease	0.0213	0.312	CbGeAlD
Procainamide—CYP2D6—Niacin—coronary artery disease	0.0125	0.0438	CbGbCtD
Procainamide—CYP2D6—Timolol—coronary artery disease	0.0116	0.0408	CbGbCtD
Procainamide—SCN5A—endocardium—coronary artery disease	0.011	0.16	CbGeAlD
Procainamide—SCN5A—sinoatrial node—coronary artery disease	0.0104	0.152	CbGeAlD
Procainamide—CYP2D6—Captopril—coronary artery disease	0.0102	0.0359	CbGbCtD
Procainamide—CYP2D6—Simvastatin—coronary artery disease	0.00986	0.0347	CbGbCtD
Procainamide—CYP2D6—Pravastatin—coronary artery disease	0.00965	0.0339	CbGbCtD
Procainamide—CYP2D6—Lovastatin—coronary artery disease	0.00965	0.0339	CbGbCtD
Procainamide—CYP2D6—Atorvastatin—coronary artery disease	0.00879	0.0309	CbGbCtD
Procainamide—SCN7A—cardiac ventricle—coronary artery disease	0.0017	0.0249	CbGeAlD
Procainamide—SCN7A—myocardium—coronary artery disease	0.0016	0.0234	CbGeAlD
Procainamide—DNMT1—Lovastatin—Simvastatin—coronary artery disease	0.00154	0.5	CbGdCrCtD
Procainamide—DNMT1—Lovastatin—Pravastatin—coronary artery disease	0.00154	0.5	CbGdCrCtD
Procainamide—DNMT1—cardiac ventricle—coronary artery disease	0.00131	0.0191	CbGeAlD
Procainamide—DNMT1—myocardium—coronary artery disease	0.00123	0.018	CbGeAlD
Procainamide—SCN7A—heart—coronary artery disease	0.00112	0.0164	CbGeAlD
Procainamide—SCN7A—cardiovascular system—coronary artery disease	0.00106	0.0154	CbGeAlD
Procainamide—Metoclopramide—CYP11B2—coronary artery disease	0.001	0.302	CrCbGaD
Procainamide—SCN7A—cardiac atrium—coronary artery disease	0.000957	0.014	CbGeAlD
Procainamide—SCN5A—cardiac ventricle—coronary artery disease	0.000924	0.0135	CbGeAlD
Procainamide—SCN5A—myocardium—coronary artery disease	0.000869	0.0127	CbGeAlD
Procainamide—DNMT1—heart—coronary artery disease	0.00086	0.0126	CbGeAlD
Procainamide—DNMT1—cardiovascular system—coronary artery disease	0.000811	0.0119	CbGeAlD
Procainamide—SCN4A—heart—coronary artery disease	0.000782	0.0114	CbGeAlD
Procainamide—DNMT1—cardiac atrium—coronary artery disease	0.000735	0.0108	CbGeAlD
Procainamide—ACHE—heart—coronary artery disease	0.000698	0.0102	CbGeAlD
Procainamide—DNMT1—blood—coronary artery disease	0.000642	0.00938	CbGeAlD
Procainamide—Sunitinib—RPS6KB1—coronary artery disease	0.000633	0.191	CrCbGaD
Procainamide—SCN3A—heart—coronary artery disease	0.000608	0.00889	CbGeAlD
Procainamide—SCN5A—heart—coronary artery disease	0.000607	0.00887	CbGeAlD
Procainamide—SCN5A—cardiovascular system—coronary artery disease	0.000572	0.00837	CbGeAlD
Procainamide—SLC22A5—cardiac ventricle—coronary artery disease	0.000537	0.00785	CbGeAlD
Procainamide—SLC22A4—heart—coronary artery disease	0.000533	0.00779	CbGeAlD
Procainamide—Sunitinib—JAK2—coronary artery disease	0.000524	0.158	CrCbGaD
Procainamide—BCHE—cardiac ventricle—coronary artery disease	0.000523	0.00764	CbGeAlD
Procainamide—SCN5A—cardiac atrium—coronary artery disease	0.000519	0.00758	CbGeAlD
Procainamide—SCN2A—blood—coronary artery disease	0.000516	0.00755	CbGeAlD
Procainamide—CHRM2—heart—coronary artery disease	0.000516	0.00755	CbGeAlD
Procainamide—SLC22A5—myocardium—coronary artery disease	0.000505	0.00738	CbGeAlD
Procainamide—SCN10A—blood—coronary artery disease	0.000498	0.00728	CbGeAlD
Procainamide—CHRM2—cardiovascular system—coronary artery disease	0.000487	0.00712	CbGeAlD
Procainamide—SCN3A—blood—coronary artery disease	0.000454	0.00664	CbGeAlD
Procainamide—SCN5A—blood—coronary artery disease	0.000453	0.00662	CbGeAlD
Procainamide—SLC22A4—blood—coronary artery disease	0.000397	0.00581	CbGeAlD
Procainamide—SLC22A1—blood—coronary artery disease	0.000378	0.00553	CbGeAlD
Procainamide—SLC22A5—heart—coronary artery disease	0.000352	0.00515	CbGeAlD
Procainamide—BCHE—heart—coronary artery disease	0.000343	0.00502	CbGeAlD
Procainamide—BCHE—cardiovascular system—coronary artery disease	0.000324	0.00474	CbGeAlD
Procainamide—Sunitinib—KDR—coronary artery disease	0.000309	0.0933	CrCbGaD
Procainamide—Moclobemide—CYP2C19—coronary artery disease	0.000303	0.0915	CrCbGaD
Procainamide—SLC22A5—cardiac atrium—coronary artery disease	0.000301	0.00441	CbGeAlD
Procainamide—BCHE—cardiac atrium—coronary artery disease	0.000294	0.00429	CbGeAlD
Procainamide—Sunitinib—KIT—coronary artery disease	0.000292	0.0881	CrCbGaD
Procainamide—SLC22A5—blood—coronary artery disease	0.000263	0.00385	CbGeAlD
Procainamide—BCHE—blood—coronary artery disease	0.000256	0.00375	CbGeAlD
Procainamide—CYP2D6—blood—coronary artery disease	0.00017	0.00248	CbGeAlD
Procainamide—Probenecid—CYP2C19—coronary artery disease	0.000161	0.0487	CrCbGaD
Procainamide—Asthenia—Lovastatin—coronary artery disease	0.00012	0.000622	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Captopril—coronary artery disease	0.000119	0.000619	CcSEcCtD
Procainamide—Decreased appetite—Trandolapril—coronary artery disease	0.000119	0.000618	CcSEcCtD
Procainamide—Pruritus—Clopidogrel—coronary artery disease	0.000119	0.000617	CcSEcCtD
Procainamide—Hypotension—Perindopril—coronary artery disease	0.000119	0.000617	CcSEcCtD
Procainamide—Decreased appetite—Enalapril—coronary artery disease	0.000119	0.000616	CcSEcCtD
Procainamide—Pruritus—Lovastatin—coronary artery disease	0.000118	0.000613	CcSEcCtD
Procainamide—Anorexia—Furosemide—coronary artery disease	0.000118	0.000611	CcSEcCtD
Procainamide—Asthenia—Ezetimibe—coronary artery disease	0.000117	0.00061	CcSEcCtD
Procainamide—Shock—Losartan—coronary artery disease	0.000117	0.000609	CcSEcCtD
Procainamide—Gastrointestinal pain—Niacin—coronary artery disease	0.000117	0.000608	CcSEcCtD
Procainamide—Urticaria—Valsartan—coronary artery disease	0.000117	0.000608	CcSEcCtD
Procainamide—Chills—Lisinopril—coronary artery disease	0.000117	0.000608	CcSEcCtD
Procainamide—Decreased appetite—Telmisartan—coronary artery disease	0.000117	0.000608	CcSEcCtD
Procainamide—Nausea—Rosuvastatin—coronary artery disease	0.000117	0.000607	CcSEcCtD
Procainamide—Diarrhoea—Fenofibrate—coronary artery disease	0.000117	0.000607	CcSEcCtD
Procainamide—Thrombocytopenia—Losartan—coronary artery disease	0.000117	0.000606	CcSEcCtD
Procainamide—Urticaria—Olmesartan—coronary artery disease	0.000117	0.000605	CcSEcCtD
Procainamide—Abdominal pain—Valsartan—coronary artery disease	0.000117	0.000605	CcSEcCtD
Procainamide—Feeling abnormal—Pravastatin—coronary artery disease	0.000116	0.000604	CcSEcCtD
Procainamide—Ill-defined disorder—Ramipril—coronary artery disease	0.000116	0.000603	CcSEcCtD
Procainamide—Abdominal pain—Olmesartan—coronary artery disease	0.000116	0.000602	CcSEcCtD
Procainamide—Body temperature increased—Olmesartan—coronary artery disease	0.000116	0.000602	CcSEcCtD
Procainamide—Pruritus—Ezetimibe—coronary artery disease	0.000116	0.000601	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000116	0.000601	CcSEcCtD
Procainamide—Hypotension—Furosemide—coronary artery disease	0.000115	0.000599	CcSEcCtD
Procainamide—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000115	0.000599	CcSEcCtD
Procainamide—Hypersensitivity—Simvastatin—coronary artery disease	0.000115	0.000597	CcSEcCtD
Procainamide—Diarrhoea—Clopidogrel—coronary artery disease	0.000115	0.000597	CcSEcCtD
Procainamide—Asthenia—Eplerenone—coronary artery disease	0.000115	0.000597	CcSEcCtD
Procainamide—Angioedema—Ramipril—coronary artery disease	0.000114	0.000594	CcSEcCtD
Procainamide—Diarrhoea—Lovastatin—coronary artery disease	0.000114	0.000593	CcSEcCtD
Procainamide—Urticaria—Niacin—coronary artery disease	0.000114	0.000591	CcSEcCtD
Procainamide—Decreased appetite—Captopril—coronary artery disease	0.000114	0.000591	CcSEcCtD
Procainamide—Anorexia—Losartan—coronary artery disease	0.000114	0.00059	CcSEcCtD
Procainamide—Nausea—Acetylsalicylic acid—coronary artery disease	0.000114	0.00059	CcSEcCtD
Procainamide—Pruritus—Eplerenone—coronary artery disease	0.000113	0.000588	CcSEcCtD
Procainamide—Abdominal pain—Niacin—coronary artery disease	0.000113	0.000588	CcSEcCtD
Procainamide—Body temperature increased—Niacin—coronary artery disease	0.000113	0.000588	CcSEcCtD
Procainamide—Dizziness—Fenofibrate—coronary artery disease	0.000113	0.000587	CcSEcCtD
Procainamide—Malaise—Ramipril—coronary artery disease	0.000113	0.000586	CcSEcCtD
Procainamide—Feeling abnormal—Trandolapril—coronary artery disease	0.000113	0.000586	CcSEcCtD
Procainamide—Feeling abnormal—Enalapril—coronary artery disease	0.000112	0.000584	CcSEcCtD
Procainamide—Urticaria—Pravastatin—coronary artery disease	0.000112	0.000582	CcSEcCtD
Procainamide—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000112	0.000582	CcSEcCtD
Procainamide—Asthenia—Simvastatin—coronary artery disease	0.000112	0.000581	CcSEcCtD
Procainamide—Diarrhoea—Ezetimibe—coronary artery disease	0.000112	0.000581	CcSEcCtD
Procainamide—Angioedema—Timolol—coronary artery disease	0.000112	0.000581	CcSEcCtD
Procainamide—Gastrointestinal pain—Enalapril—coronary artery disease	0.000112	0.000579	CcSEcCtD
Procainamide—Body temperature increased—Pravastatin—coronary artery disease	0.000112	0.000579	CcSEcCtD
Procainamide—Abdominal pain—Pravastatin—coronary artery disease	0.000112	0.000579	CcSEcCtD
Procainamide—Hypotension—Losartan—coronary artery disease	0.000111	0.000578	CcSEcCtD
Procainamide—Dysgeusia—Lisinopril—coronary artery disease	0.000111	0.000577	CcSEcCtD
Procainamide—Dizziness—Clopidogrel—coronary artery disease	0.000111	0.000577	CcSEcCtD
Procainamide—Feeling abnormal—Telmisartan—coronary artery disease	0.000111	0.000576	CcSEcCtD
Procainamide—Decreased appetite—Perindopril—coronary artery disease	0.000111	0.000574	CcSEcCtD
Procainamide—Pruritus—Simvastatin—coronary artery disease	0.00011	0.000573	CcSEcCtD
Procainamide—Dizziness—Lovastatin—coronary artery disease	0.00011	0.000573	CcSEcCtD
Procainamide—Gastrointestinal pain—Telmisartan—coronary artery disease	0.00011	0.000571	CcSEcCtD
Procainamide—Diarrhoea—Eplerenone—coronary artery disease	0.00011	0.000569	CcSEcCtD
Procainamide—Urticaria—Trandolapril—coronary artery disease	0.000109	0.000565	CcSEcCtD
Procainamide—Vomiting—Fenofibrate—coronary artery disease	0.000109	0.000564	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000109	0.000564	CcSEcCtD
Procainamide—Hypersensitivity—Valsartan—coronary artery disease	0.000109	0.000564	CcSEcCtD
Procainamide—Convulsion—Ramipril—coronary artery disease	0.000109	0.000563	CcSEcCtD
Procainamide—Urticaria—Enalapril—coronary artery disease	0.000108	0.000563	CcSEcCtD
Procainamide—Abdominal pain—Trandolapril—coronary artery disease	0.000108	0.000562	CcSEcCtD
Procainamide—Body temperature increased—Trandolapril—coronary artery disease	0.000108	0.000562	CcSEcCtD
Procainamide—Dizziness—Ezetimibe—coronary artery disease	0.000108	0.000562	CcSEcCtD
Procainamide—Abdominal pain—Enalapril—coronary artery disease	0.000108	0.00056	CcSEcCtD
Procainamide—Body temperature increased—Enalapril—coronary artery disease	0.000108	0.00056	CcSEcCtD
Procainamide—Feeling abnormal—Captopril—coronary artery disease	0.000108	0.00056	CcSEcCtD
Procainamide—Decreased appetite—Furosemide—coronary artery disease	0.000107	0.000558	CcSEcCtD
Procainamide—Gastrointestinal pain—Captopril—coronary artery disease	0.000107	0.000556	CcSEcCtD
Procainamide—Urticaria—Telmisartan—coronary artery disease	0.000107	0.000555	CcSEcCtD
Procainamide—Vomiting—Clopidogrel—coronary artery disease	0.000107	0.000554	CcSEcCtD
Procainamide—Diarrhoea—Simvastatin—coronary artery disease	0.000107	0.000554	CcSEcCtD
Procainamide—Arthralgia—Ramipril—coronary artery disease	0.000107	0.000554	CcSEcCtD
Procainamide—Myalgia—Ramipril—coronary artery disease	0.000107	0.000554	CcSEcCtD
Procainamide—Abdominal pain—Telmisartan—coronary artery disease	0.000106	0.000552	CcSEcCtD
Procainamide—Body temperature increased—Telmisartan—coronary artery disease	0.000106	0.000552	CcSEcCtD
Procainamide—Vomiting—Lovastatin—coronary artery disease	0.000106	0.000551	CcSEcCtD
Procainamide—Dizziness—Eplerenone—coronary artery disease	0.000106	0.00055	CcSEcCtD
Procainamide—Asthenia—Valsartan—coronary artery disease	0.000106	0.000549	CcSEcCtD
Procainamide—Hypersensitivity—Niacin—coronary artery disease	0.000106	0.000548	CcSEcCtD
Procainamide—Ill-defined disorder—Lisinopril—coronary artery disease	0.000105	0.000547	CcSEcCtD
Procainamide—Discomfort—Ramipril—coronary artery disease	0.000105	0.000547	CcSEcCtD
Procainamide—Asthenia—Olmesartan—coronary artery disease	0.000105	0.000546	CcSEcCtD
Procainamide—Feeling abnormal—Perindopril—coronary artery disease	0.000105	0.000544	CcSEcCtD
Procainamide—Pruritus—Valsartan—coronary artery disease	0.000104	0.000541	CcSEcCtD
Procainamide—Myalgia—Timolol—coronary artery disease	0.000104	0.000541	CcSEcCtD
Procainamide—Arthralgia—Timolol—coronary artery disease	0.000104	0.000541	CcSEcCtD
Procainamide—Vomiting—Ezetimibe—coronary artery disease	0.000104	0.00054	CcSEcCtD
Procainamide—Hypersensitivity—Pravastatin—coronary artery disease	0.000104	0.00054	CcSEcCtD
Procainamide—Gastrointestinal pain—Perindopril—coronary artery disease	0.000104	0.00054	CcSEcCtD
Procainamide—Angioedema—Lisinopril—coronary artery disease	0.000104	0.000539	CcSEcCtD
Procainamide—Pruritus—Olmesartan—coronary artery disease	0.000104	0.000539	CcSEcCtD
Procainamide—Decreased appetite—Losartan—coronary artery disease	0.000104	0.000538	CcSEcCtD
Procainamide—Abdominal pain—Captopril—coronary artery disease	0.000104	0.000537	CcSEcCtD
Procainamide—Body temperature increased—Captopril—coronary artery disease	0.000104	0.000537	CcSEcCtD
Procainamide—Dizziness—Simvastatin—coronary artery disease	0.000103	0.000536	CcSEcCtD
Procainamide—Confusional state—Ramipril—coronary artery disease	0.000103	0.000535	CcSEcCtD
Procainamide—Discomfort—Timolol—coronary artery disease	0.000103	0.000535	CcSEcCtD
Procainamide—Asthenia—Niacin—coronary artery disease	0.000103	0.000534	CcSEcCtD
Procainamide—Malaise—Lisinopril—coronary artery disease	0.000102	0.000532	CcSEcCtD
Procainamide—Vomiting—Eplerenone—coronary artery disease	0.000102	0.000529	CcSEcCtD
Procainamide—Feeling abnormal—Furosemide—coronary artery disease	0.000102	0.000529	CcSEcCtD
Procainamide—Nausea—Fenofibrate—coronary artery disease	0.000102	0.000527	CcSEcCtD
Procainamide—Pruritus—Niacin—coronary artery disease	0.000101	0.000526	CcSEcCtD
Procainamide—Asthenia—Pravastatin—coronary artery disease	0.000101	0.000526	CcSEcCtD
Procainamide—Gastrointestinal pain—Furosemide—coronary artery disease	0.000101	0.000525	CcSEcCtD
Procainamide—Urticaria—Perindopril—coronary artery disease	0.000101	0.000524	CcSEcCtD
Procainamide—Hypersensitivity—Trandolapril—coronary artery disease	0.000101	0.000524	CcSEcCtD
Procainamide—Diarrhoea—Valsartan—coronary artery disease	0.000101	0.000524	CcSEcCtD
Procainamide—Confusional state—Timolol—coronary artery disease	0.000101	0.000523	CcSEcCtD
Procainamide—Shock—Ramipril—coronary artery disease	0.000101	0.000522	CcSEcCtD
Procainamide—Hypersensitivity—Enalapril—coronary artery disease	0.000101	0.000522	CcSEcCtD
Procainamide—Abdominal pain—Perindopril—coronary artery disease	0.0001	0.000522	CcSEcCtD
Procainamide—Body temperature increased—Perindopril—coronary artery disease	0.0001	0.000522	CcSEcCtD
Procainamide—Diarrhoea—Olmesartan—coronary artery disease	0.0001	0.000521	CcSEcCtD
Procainamide—Thrombocytopenia—Ramipril—coronary artery disease	0.0001	0.00052	CcSEcCtD
Procainamide—Pruritus—Pravastatin—coronary artery disease	9.99e-05	0.000518	CcSEcCtD
Procainamide—Nausea—Clopidogrel—coronary artery disease	9.98e-05	0.000518	CcSEcCtD
Procainamide—Vomiting—Simvastatin—coronary artery disease	9.93e-05	0.000515	CcSEcCtD
Procainamide—Hypersensitivity—Telmisartan—coronary artery disease	9.92e-05	0.000515	CcSEcCtD
Procainamide—Nausea—Lovastatin—coronary artery disease	9.91e-05	0.000515	CcSEcCtD
Procainamide—Asthenia—Trandolapril—coronary artery disease	9.83e-05	0.00051	CcSEcCtD
Procainamide—Shock—Timolol—coronary artery disease	9.83e-05	0.00051	CcSEcCtD
Procainamide—Feeling abnormal—Losartan—coronary artery disease	9.83e-05	0.00051	CcSEcCtD
Procainamide—Urticaria—Furosemide—coronary artery disease	9.82e-05	0.00051	CcSEcCtD
Procainamide—Diarrhoea—Niacin—coronary artery disease	9.81e-05	0.000509	CcSEcCtD
Procainamide—Asthenia—Enalapril—coronary artery disease	9.79e-05	0.000508	CcSEcCtD
Procainamide—Abdominal pain—Furosemide—coronary artery disease	9.77e-05	0.000507	CcSEcCtD
Procainamide—Body temperature increased—Furosemide—coronary artery disease	9.77e-05	0.000507	CcSEcCtD
Procainamide—Gastrointestinal pain—Losartan—coronary artery disease	9.75e-05	0.000506	CcSEcCtD
Procainamide—Dizziness—Valsartan—coronary artery disease	9.75e-05	0.000506	CcSEcCtD
Procainamide—Anorexia—Ramipril—coronary artery disease	9.75e-05	0.000506	CcSEcCtD
Procainamide—Nausea—Ezetimibe—coronary artery disease	9.72e-05	0.000505	CcSEcCtD
Procainamide—Dizziness—Olmesartan—coronary artery disease	9.7e-05	0.000504	CcSEcCtD
Procainamide—Pruritus—Trandolapril—coronary artery disease	9.7e-05	0.000503	CcSEcCtD
Procainamide—Arthralgia—Lisinopril—coronary artery disease	9.67e-05	0.000502	CcSEcCtD
Procainamide—Myalgia—Lisinopril—coronary artery disease	9.67e-05	0.000502	CcSEcCtD
Procainamide—Asthenia—Telmisartan—coronary artery disease	9.66e-05	0.000501	CcSEcCtD
Procainamide—Pruritus—Enalapril—coronary artery disease	9.66e-05	0.000501	CcSEcCtD
Procainamide—Diarrhoea—Pravastatin—coronary artery disease	9.66e-05	0.000501	CcSEcCtD
Procainamide—Discomfort—Lisinopril—coronary artery disease	9.56e-05	0.000496	CcSEcCtD
Procainamide—Hypotension—Ramipril—coronary artery disease	9.55e-05	0.000496	CcSEcCtD
Procainamide—Anorexia—Timolol—coronary artery disease	9.53e-05	0.000495	CcSEcCtD
Procainamide—Pruritus—Telmisartan—coronary artery disease	9.53e-05	0.000494	CcSEcCtD
Procainamide—Nausea—Eplerenone—coronary artery disease	9.52e-05	0.000494	CcSEcCtD
Procainamide—Dizziness—Niacin—coronary artery disease	9.48e-05	0.000492	CcSEcCtD
Procainamide—Urticaria—Losartan—coronary artery disease	9.47e-05	0.000492	CcSEcCtD
Procainamide—Abdominal pain—Losartan—coronary artery disease	9.43e-05	0.000489	CcSEcCtD
Procainamide—Body temperature increased—Losartan—coronary artery disease	9.43e-05	0.000489	CcSEcCtD
Procainamide—Asthenia—Captopril—coronary artery disease	9.39e-05	0.000488	CcSEcCtD
Procainamide—Diarrhoea—Trandolapril—coronary artery disease	9.38e-05	0.000487	CcSEcCtD
Procainamide—Vomiting—Valsartan—coronary artery disease	9.37e-05	0.000487	CcSEcCtD
Procainamide—Confusional state—Lisinopril—coronary artery disease	9.35e-05	0.000485	CcSEcCtD
Procainamide—Diarrhoea—Enalapril—coronary artery disease	9.34e-05	0.000485	CcSEcCtD
Procainamide—Hypotension—Timolol—coronary artery disease	9.34e-05	0.000485	CcSEcCtD
Procainamide—Dizziness—Pravastatin—coronary artery disease	9.33e-05	0.000484	CcSEcCtD
Procainamide—Vomiting—Olmesartan—coronary artery disease	9.33e-05	0.000484	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Ramipril—coronary artery disease	9.32e-05	0.000483	CcSEcCtD
Procainamide—Nausea—Simvastatin—coronary artery disease	9.27e-05	0.000481	CcSEcCtD
Procainamide—Pruritus—Captopril—coronary artery disease	9.26e-05	0.000481	CcSEcCtD
Procainamide—Diarrhoea—Telmisartan—coronary artery disease	9.21e-05	0.000478	CcSEcCtD
Procainamide—Shock—Lisinopril—coronary artery disease	9.12e-05	0.000473	CcSEcCtD
Procainamide—Asthenia—Perindopril—coronary artery disease	9.12e-05	0.000473	CcSEcCtD
Procainamide—Vomiting—Niacin—coronary artery disease	9.11e-05	0.000473	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Timolol—coronary artery disease	9.11e-05	0.000473	CcSEcCtD
Procainamide—Hypersensitivity—Furosemide—coronary artery disease	9.11e-05	0.000473	CcSEcCtD
Procainamide—Thrombocytopenia—Lisinopril—coronary artery disease	9.08e-05	0.000471	CcSEcCtD
Procainamide—Dizziness—Trandolapril—coronary artery disease	9.06e-05	0.00047	CcSEcCtD
Procainamide—Dizziness—Enalapril—coronary artery disease	9.03e-05	0.000469	CcSEcCtD
Procainamide—Pruritus—Perindopril—coronary artery disease	8.99e-05	0.000467	CcSEcCtD
Procainamide—Vomiting—Pravastatin—coronary artery disease	8.97e-05	0.000466	CcSEcCtD
Procainamide—Diarrhoea—Captopril—coronary artery disease	8.96e-05	0.000465	CcSEcCtD
Procainamide—Probenecid—ALB—coronary artery disease	8.95e-05	0.027	CrCbGaD
Procainamide—Dizziness—Telmisartan—coronary artery disease	8.9e-05	0.000462	CcSEcCtD
Procainamide—Decreased appetite—Ramipril—coronary artery disease	8.89e-05	0.000461	CcSEcCtD
Procainamide—Asthenia—Furosemide—coronary artery disease	8.87e-05	0.00046	CcSEcCtD
Procainamide—Anorexia—Lisinopril—coronary artery disease	8.84e-05	0.000459	CcSEcCtD
Procainamide—Hypersensitivity—Losartan—coronary artery disease	8.79e-05	0.000456	CcSEcCtD
Procainamide—Nausea—Valsartan—coronary artery disease	8.76e-05	0.000455	CcSEcCtD
Procainamide—Pruritus—Furosemide—coronary artery disease	8.74e-05	0.000454	CcSEcCtD
Procainamide—Nausea—Olmesartan—coronary artery disease	8.72e-05	0.000452	CcSEcCtD
Procainamide—Vomiting—Trandolapril—coronary artery disease	8.72e-05	0.000452	CcSEcCtD
Procainamide—Diarrhoea—Perindopril—coronary artery disease	8.7e-05	0.000451	CcSEcCtD
Procainamide—Decreased appetite—Timolol—coronary artery disease	8.69e-05	0.000451	CcSEcCtD
Procainamide—Vomiting—Enalapril—coronary artery disease	8.68e-05	0.000451	CcSEcCtD
Procainamide—Hypotension—Lisinopril—coronary artery disease	8.66e-05	0.00045	CcSEcCtD
Procainamide—Dizziness—Captopril—coronary artery disease	8.66e-05	0.000449	CcSEcCtD
Procainamide—Vomiting—Telmisartan—coronary artery disease	8.56e-05	0.000444	CcSEcCtD
Procainamide—Asthenia—Losartan—coronary artery disease	8.56e-05	0.000444	CcSEcCtD
Procainamide—Nausea—Niacin—coronary artery disease	8.52e-05	0.000442	CcSEcCtD
Procainamide—Diarrhoea—Furosemide—coronary artery disease	8.46e-05	0.000439	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.45e-05	0.000438	CcSEcCtD
Procainamide—Pruritus—Losartan—coronary artery disease	8.44e-05	0.000438	CcSEcCtD
Procainamide—Feeling abnormal—Ramipril—coronary artery disease	8.43e-05	0.000437	CcSEcCtD
Procainamide—Dizziness—Perindopril—coronary artery disease	8.41e-05	0.000436	CcSEcCtD
Procainamide—Nausea—Pravastatin—coronary artery disease	8.38e-05	0.000435	CcSEcCtD
Procainamide—Gastrointestinal pain—Ramipril—coronary artery disease	8.36e-05	0.000434	CcSEcCtD
Procainamide—Vomiting—Captopril—coronary artery disease	8.33e-05	0.000432	CcSEcCtD
Procainamide—Feeling abnormal—Timolol—coronary artery disease	8.24e-05	0.000428	CcSEcCtD
Procainamide—Gastrointestinal pain—Timolol—coronary artery disease	8.17e-05	0.000424	CcSEcCtD
Procainamide—Dizziness—Furosemide—coronary artery disease	8.17e-05	0.000424	CcSEcCtD
Procainamide—Diarrhoea—Losartan—coronary artery disease	8.16e-05	0.000423	CcSEcCtD
Procainamide—Nausea—Trandolapril—coronary artery disease	8.14e-05	0.000423	CcSEcCtD
Procainamide—Urticaria—Ramipril—coronary artery disease	8.12e-05	0.000422	CcSEcCtD
Procainamide—Nausea—Enalapril—coronary artery disease	8.11e-05	0.000421	CcSEcCtD
Procainamide—Vomiting—Perindopril—coronary artery disease	8.08e-05	0.00042	CcSEcCtD
Procainamide—Body temperature increased—Ramipril—coronary artery disease	8.08e-05	0.00042	CcSEcCtD
Procainamide—Abdominal pain—Ramipril—coronary artery disease	8.08e-05	0.00042	CcSEcCtD
Procainamide—Decreased appetite—Lisinopril—coronary artery disease	8.06e-05	0.000418	CcSEcCtD
Procainamide—Nausea—Telmisartan—coronary artery disease	8e-05	0.000415	CcSEcCtD
Procainamide—Urticaria—Timolol—coronary artery disease	7.94e-05	0.000412	CcSEcCtD
Procainamide—Abdominal pain—Timolol—coronary artery disease	7.9e-05	0.00041	CcSEcCtD
Procainamide—Body temperature increased—Timolol—coronary artery disease	7.9e-05	0.00041	CcSEcCtD
Procainamide—Dizziness—Losartan—coronary artery disease	7.89e-05	0.000409	CcSEcCtD
Procainamide—Vomiting—Furosemide—coronary artery disease	7.86e-05	0.000408	CcSEcCtD
Procainamide—Nausea—Captopril—coronary artery disease	7.78e-05	0.000404	CcSEcCtD
Procainamide—Feeling abnormal—Lisinopril—coronary artery disease	7.64e-05	0.000397	CcSEcCtD
Procainamide—Gastrointestinal pain—Lisinopril—coronary artery disease	7.58e-05	0.000394	CcSEcCtD
Procainamide—Vomiting—Losartan—coronary artery disease	7.58e-05	0.000394	CcSEcCtD
Procainamide—Nausea—Perindopril—coronary artery disease	7.55e-05	0.000392	CcSEcCtD
Procainamide—Hypersensitivity—Ramipril—coronary artery disease	7.53e-05	0.000391	CcSEcCtD
Procainamide—Urticaria—Lisinopril—coronary artery disease	7.37e-05	0.000382	CcSEcCtD
Procainamide—Hypersensitivity—Timolol—coronary artery disease	7.36e-05	0.000382	CcSEcCtD
Procainamide—Nausea—Furosemide—coronary artery disease	7.34e-05	0.000381	CcSEcCtD
Procainamide—Asthenia—Ramipril—coronary artery disease	7.34e-05	0.000381	CcSEcCtD
Procainamide—Abdominal pain—Lisinopril—coronary artery disease	7.33e-05	0.00038	CcSEcCtD
Procainamide—Body temperature increased—Lisinopril—coronary artery disease	7.33e-05	0.00038	CcSEcCtD
Procainamide—Pruritus—Ramipril—coronary artery disease	7.23e-05	0.000375	CcSEcCtD
Procainamide—Asthenia—Timolol—coronary artery disease	7.17e-05	0.000372	CcSEcCtD
Procainamide—Nausea—Losartan—coronary artery disease	7.08e-05	0.000368	CcSEcCtD
Procainamide—Pruritus—Timolol—coronary artery disease	7.07e-05	0.000367	CcSEcCtD
Procainamide—Diarrhoea—Ramipril—coronary artery disease	7e-05	0.000363	CcSEcCtD
Procainamide—Diarrhoea—Timolol—coronary artery disease	6.84e-05	0.000355	CcSEcCtD
Procainamide—Hypersensitivity—Lisinopril—coronary artery disease	6.83e-05	0.000355	CcSEcCtD
Procainamide—Dizziness—Ramipril—coronary artery disease	6.76e-05	0.000351	CcSEcCtD
Procainamide—Asthenia—Lisinopril—coronary artery disease	6.65e-05	0.000345	CcSEcCtD
Procainamide—Dizziness—Timolol—coronary artery disease	6.61e-05	0.000343	CcSEcCtD
Procainamide—Pruritus—Lisinopril—coronary artery disease	6.56e-05	0.000341	CcSEcCtD
Procainamide—Vomiting—Ramipril—coronary artery disease	6.5e-05	0.000337	CcSEcCtD
Procainamide—Vomiting—Timolol—coronary artery disease	6.36e-05	0.00033	CcSEcCtD
Procainamide—Diarrhoea—Lisinopril—coronary artery disease	6.34e-05	0.000329	CcSEcCtD
Procainamide—Dizziness—Lisinopril—coronary artery disease	6.13e-05	0.000318	CcSEcCtD
Procainamide—Nausea—Ramipril—coronary artery disease	6.07e-05	0.000315	CcSEcCtD
Procainamide—Nausea—Timolol—coronary artery disease	5.94e-05	0.000308	CcSEcCtD
Procainamide—Vomiting—Lisinopril—coronary artery disease	5.9e-05	0.000306	CcSEcCtD
Procainamide—Nausea—Lisinopril—coronary artery disease	5.51e-05	0.000286	CcSEcCtD
Procainamide—CYP2D6—Metabolism—HADH—coronary artery disease	4.99e-06	4.46e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOB—coronary artery disease	4.99e-06	4.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ATP2A2—coronary artery disease	4.97e-06	4.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SH2B3—coronary artery disease	4.97e-06	4.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VWF—coronary artery disease	4.97e-06	4.44e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—coronary artery disease	4.95e-06	4.43e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOC3—coronary artery disease	4.94e-06	4.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LDLR—coronary artery disease	4.91e-06	4.39e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT1—coronary artery disease	4.89e-06	4.37e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GGT1—coronary artery disease	4.89e-06	4.37e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—coronary artery disease	4.88e-06	4.36e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—coronary artery disease	4.85e-06	4.34e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AGT—coronary artery disease	4.83e-06	4.32e-05	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—coronary artery disease	4.81e-06	4.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PPP2CA—coronary artery disease	4.81e-06	4.3e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—coronary artery disease	4.8e-06	4.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL2—coronary artery disease	4.79e-06	4.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL3—coronary artery disease	4.79e-06	4.28e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—LPL—coronary artery disease	4.76e-06	4.26e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SDC1—coronary artery disease	4.74e-06	4.24e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2R—coronary artery disease	4.74e-06	4.24e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX2—coronary artery disease	4.73e-06	4.23e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	4.73e-06	4.23e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA2—coronary artery disease	4.73e-06	4.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PRKCD—coronary artery disease	4.73e-06	4.23e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTP1—coronary artery disease	4.71e-06	4.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SULT1A1—coronary artery disease	4.67e-06	4.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HK1—coronary artery disease	4.67e-06	4.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX4—coronary artery disease	4.67e-06	4.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCG5—coronary artery disease	4.67e-06	4.18e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARGC1A—coronary artery disease	4.67e-06	4.18e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—coronary artery disease	4.65e-06	4.16e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GPX1—coronary artery disease	4.64e-06	4.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGB—coronary artery disease	4.64e-06	4.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—coronary artery disease	4.63e-06	4.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C3—coronary artery disease	4.62e-06	4.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HADHA—coronary artery disease	4.62e-06	4.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRB—coronary artery disease	4.59e-06	4.1e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CAT—coronary artery disease	4.59e-06	4.1e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTA1—coronary artery disease	4.57e-06	4.08e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AGT—coronary artery disease	4.56e-06	4.08e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CD36—coronary artery disease	4.52e-06	4.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—THBS1—coronary artery disease	4.52e-06	4.04e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPA—coronary artery disease	4.51e-06	4.04e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMA6—coronary artery disease	4.48e-06	4e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PSMB5—coronary artery disease	4.48e-06	4e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOE—coronary artery disease	4.47e-06	4e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—F2—coronary artery disease	4.47e-06	3.99e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPP2CA—coronary artery disease	4.47e-06	3.99e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOB—coronary artery disease	4.45e-06	3.98e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—coronary artery disease	4.45e-06	3.98e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—APOA1—coronary artery disease	4.42e-06	3.95e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTP1—coronary artery disease	4.39e-06	3.93e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AGT—coronary artery disease	4.39e-06	3.92e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLCB3—coronary artery disease	4.37e-06	3.91e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARGC1A—coronary artery disease	4.35e-06	3.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDNRA—coronary artery disease	4.33e-06	3.87e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—coronary artery disease	4.33e-06	3.87e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—coronary artery disease	4.33e-06	3.87e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA5—coronary artery disease	4.33e-06	3.87e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CYBA—coronary artery disease	4.31e-06	3.86e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB1—coronary artery disease	4.31e-06	3.86e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DUSP6—coronary artery disease	4.3e-06	3.84e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—coronary artery disease	4.29e-06	3.83e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CAT—coronary artery disease	4.27e-06	3.82e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—coronary artery disease	4.26e-06	3.81e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—LPL—coronary artery disease	4.25e-06	3.8e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—P4HB—coronary artery disease	4.24e-06	3.8e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.23e-06	3.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLAT—coronary artery disease	4.22e-06	3.78e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	4.17e-06	3.73e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOB—coronary artery disease	4.15e-06	3.71e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GPX1—coronary artery disease	4.15e-06	3.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL12—coronary artery disease	4.07e-06	3.64e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—BDKRB2—coronary artery disease	4.07e-06	3.64e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AGT—coronary artery disease	4.07e-06	3.64e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—coronary artery disease	4.07e-06	3.64e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—F2—coronary artery disease	4.06e-06	3.63e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6ST—coronary artery disease	4.04e-06	3.61e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CD36—coronary artery disease	4.04e-06	3.61e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—coronary artery disease	4.04e-06	3.61e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JUNB—coronary artery disease	4e-06	3.58e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOE—coronary artery disease	3.99e-06	3.57e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPP2CA—coronary artery disease	3.99e-06	3.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	3.99e-06	3.56e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—LPL—coronary artery disease	3.96e-06	3.54e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—APOA1—coronary artery disease	3.94e-06	3.53e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—VCAN—coronary artery disease	3.93e-06	3.51e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR7—coronary artery disease	3.9e-06	3.49e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDOA—coronary artery disease	3.9e-06	3.48e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—coronary artery disease	3.9e-06	3.48e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—coronary artery disease	3.89e-06	3.48e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GPX1—coronary artery disease	3.87e-06	3.46e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—coronary artery disease	3.84e-06	3.44e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—coronary artery disease	3.83e-06	3.42e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DCN—coronary artery disease	3.78e-06	3.38e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.78e-06	3.38e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CD36—coronary artery disease	3.77e-06	3.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	3.72e-06	3.32e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPP2CA—coronary artery disease	3.72e-06	3.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KNG1—coronary artery disease	3.71e-06	3.31e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—coronary artery disease	3.69e-06	3.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	3.69e-06	3.3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	3.68e-06	3.29e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDH2—coronary artery disease	3.68e-06	3.29e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AGT—coronary artery disease	3.64e-06	3.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	3.62e-06	3.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	3.6e-06	3.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	3.6e-06	3.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLG—coronary artery disease	3.59e-06	3.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LIPC—coronary artery disease	3.59e-06	3.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HBA1—coronary artery disease	3.59e-06	3.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2C19—coronary artery disease	3.59e-06	3.21e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	3.59e-06	3.21e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—coronary artery disease	3.57e-06	3.19e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOC3—coronary artery disease	3.56e-06	3.19e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOE—coronary artery disease	3.56e-06	3.19e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LDLR—coronary artery disease	3.54e-06	3.17e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—APOA1—coronary artery disease	3.52e-06	3.15e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—coronary artery disease	3.5e-06	3.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTT1—coronary artery disease	3.5e-06	3.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC9A1—coronary artery disease	3.5e-06	3.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	3.5e-06	3.13e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—coronary artery disease	3.48e-06	3.11e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCLC—coronary artery disease	3.46e-06	3.09e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CETP—coronary artery disease	3.46e-06	3.09e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	3.45e-06	3.09e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	3.45e-06	3.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	3.44e-06	3.08e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—S100B—coronary artery disease	3.43e-06	3.07e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—coronary artery disease	3.43e-06	3.06e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SDC1—coronary artery disease	3.42e-06	3.06e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	3.4e-06	3.04e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AGT—coronary artery disease	3.39e-06	3.03e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KITLG—coronary artery disease	3.36e-06	3e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	3.36e-06	3e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—coronary artery disease	3.35e-06	3e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOE—coronary artery disease	3.32e-06	2.97e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	3.28e-06	2.94e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP3—coronary artery disease	3.28e-06	2.94e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—APOA1—coronary artery disease	3.28e-06	2.94e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMB5—coronary artery disease	3.23e-06	2.89e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PSMA6—coronary artery disease	3.23e-06	2.89e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOB—coronary artery disease	3.17e-06	2.84e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CTGF—coronary artery disease	3.16e-06	2.82e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	3.15e-06	2.81e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	3.13e-06	2.8e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMGCR—coronary artery disease	3.13e-06	2.8e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT2—coronary artery disease	3.13e-06	2.8e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—coronary artery disease	3.13e-06	2.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—coronary artery disease	3.12e-06	2.79e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—coronary artery disease	3.1e-06	2.78e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL5—coronary artery disease	3.1e-06	2.77e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—coronary artery disease	3.06e-06	2.74e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—coronary artery disease	3.06e-06	2.74e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF1—coronary artery disease	3.05e-06	2.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CSF2—coronary artery disease	3.05e-06	2.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LPL—coronary artery disease	3.03e-06	2.71e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	3e-06	2.69e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	3e-06	2.69e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—coronary artery disease	2.99e-06	2.67e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	2.93e-06	2.62e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—coronary artery disease	2.89e-06	2.59e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLCB1—coronary artery disease	2.88e-06	2.57e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	2.86e-06	2.56e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—coronary artery disease	2.85e-06	2.55e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	2.84e-06	2.54e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	2.79e-06	2.5e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—coronary artery disease	2.79e-06	2.5e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ABCA1—coronary artery disease	2.79e-06	2.49e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—coronary artery disease	2.73e-06	2.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	2.73e-06	2.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C3—coronary artery disease	2.73e-06	2.44e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GGT1—coronary artery disease	2.7e-06	2.42e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT1—coronary artery disease	2.7e-06	2.42e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—coronary artery disease	2.67e-06	2.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	2.6e-06	2.33e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—coronary artery disease	2.6e-06	2.33e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AGT—coronary artery disease	2.59e-06	2.32e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOE—coronary artery disease	2.54e-06	2.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—coronary artery disease	2.54e-06	2.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APOA1—coronary artery disease	2.51e-06	2.25e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KDR—coronary artery disease	2.49e-06	2.23e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—coronary artery disease	2.49e-06	2.22e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	2.47e-06	2.21e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—coronary artery disease	2.44e-06	2.18e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTP1—coronary artery disease	2.43e-06	2.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—coronary artery disease	2.43e-06	2.17e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	2.4e-06	2.15e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2—coronary artery disease	2.4e-06	2.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FN1—coronary artery disease	2.4e-06	2.14e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—coronary artery disease	2.4e-06	2.14e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—coronary artery disease	2.39e-06	2.14e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	2.39e-06	2.13e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	2.37e-06	2.12e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CAT—coronary artery disease	2.36e-06	2.11e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KIT—coronary artery disease	2.29e-06	2.05e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOB—coronary artery disease	2.29e-06	2.05e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—coronary artery disease	2.28e-06	2.03e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—coronary artery disease	2.23e-06	1.99e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	2.2e-06	1.97e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—LPL—coronary artery disease	2.19e-06	1.96e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—coronary artery disease	2.18e-06	1.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CREB1—coronary artery disease	2.18e-06	1.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—coronary artery disease	2.14e-06	1.91e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GPX1—coronary artery disease	2.14e-06	1.91e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6R—coronary artery disease	2.13e-06	1.9e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—coronary artery disease	2.1e-06	1.88e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	2.09e-06	1.87e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CD36—coronary artery disease	2.08e-06	1.86e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPP2CA—coronary artery disease	2.05e-06	1.84e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	2e-06	1.79e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	1.99e-06	1.78e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—coronary artery disease	1.97e-06	1.76e-05	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—coronary artery disease	1.96e-06	1.75e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.93e-06	1.73e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.9e-06	1.7e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—coronary artery disease	1.89e-06	1.69e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AGT—coronary artery disease	1.87e-06	1.67e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.85e-06	1.65e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOE—coronary artery disease	1.83e-06	1.64e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APOA1—coronary artery disease	1.81e-06	1.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.81e-06	1.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.69e-06	1.51e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—coronary artery disease	1.68e-06	1.5e-05	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.63e-06	1.46e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.62e-06	1.44e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.61e-06	1.44e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—coronary artery disease	1.6e-06	1.43e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—coronary artery disease	1.58e-06	1.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.57e-06	1.41e-05	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—coronary artery disease	1.54e-06	1.38e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.53e-06	1.37e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—coronary artery disease	1.5e-06	1.34e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.48e-06	1.32e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—coronary artery disease	1.44e-06	1.28e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—coronary artery disease	1.4e-06	1.25e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—coronary artery disease	1.37e-06	1.23e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—coronary artery disease	1.37e-06	1.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.37e-06	1.23e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	1.26e-06	1.13e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—coronary artery disease	1.26e-06	1.12e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	1.23e-06	1.1e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—coronary artery disease	1.23e-06	1.1e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—coronary artery disease	1.14e-06	1.02e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.07e-06	9.58e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—coronary artery disease	9.48e-07	8.48e-06	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—coronary artery disease	8.75e-07	7.82e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—coronary artery disease	7.73e-07	6.91e-06	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—coronary artery disease	6.32e-07	5.65e-06	CbGpPWpGaD
